Skip to main content
. 2014 Mar 4;(3):1–115. doi: 10.1002/14651858.CD006404.pub2
Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Total failure PCR-unadjusted (Day 28); Sensitivity analysis 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Primary analysis (Cochrane review) 1 1200 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.17, 0.73]
1.2 Missing data included as failures 1 1271 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.49, 1.05]
1.3 Missing data included as successes 1 1271 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.17, 0.73]
1.4 Intention to treat analysis (of trial authors) 1 1271 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.49, 1.05]
1.5 Per-protocol analysis (of trial authors) 1 1120 Risk Ratio (M-H, Fixed, 95% CI) 0.36 [0.17, 0.78]
2 Total failure PCR-adjusted (Day 28); Sensitivity analysis 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Primary analysis (Cochrane review) 1 1187 Risk Ratio (M-H, Fixed, 95% CI) 0.38 [0.14, 1.02]
2.2 Missing or indeterminate PCR results included as failures 1 1187 Risk Ratio (M-H, Fixed, 95% CI) 0.38 [0.14, 1.02]
2.3 New infections included as successes 1 1200 Risk Ratio (M-H, Fixed, 95% CI) 0.39 [0.15, 1.03]
2.4 Missing data included as failures 1 1271 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.54, 1.24]
2.5 Missing data included as successes 1 1271 Risk Ratio (M-H, Fixed, 95% CI) 0.39 [0.15, 1.03]
2.6 Intention to treat analysis (by trial authors) 1 1271 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.51, 1.14]
2.7 Per-protocol analysis (by trial authors) 1 1117 Risk Ratio (M-H, Fixed, 95% CI) 0.37 [0.13, 1.05]